Highlights and Quick Summary
- Net Current Asset Value for the quarter ending September 30, 2023 was $139 Million (a -21.6% decrease compared to previous quarter)
- Year-over-year quarterly Net Current Asset Value decreased by -23.43%
- Annual Net Current Asset Value for 2022 was $182 Million (a -12.63% decrease from previous year)
- Annual Net Current Asset Value for 2021 was $208 Million (a 549.0% increase from previous year)
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Current Asset Value of Prime Medicine, Inc.
Most recent Net Current Asset Valueof PRME including historical data for past 10 years.Interactive Chart of Net Current Asset Value of Prime Medicine, Inc.
Prime Medicine, Inc. Net Current Asset Value for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $139.34 | $177.73 | $215.36 | – | – |
| 2022 | $181.97 | $106.28 | $0.0 | $0.0 | $181.97 |
| 2021 | – | – | – | $0.0 | $208.28 |
| 2020 | $0.0 | – | – | – | $32.09 |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology